Category: Zimmer Holdings
Here's a look at some of the top regulatory stories for medical device companies this week: Covidien taps integration chief to navigate Medtronic merger; Zimmer, Biomet appoint integration team; Thoratec inks $75M deal for Apica Cardiovascular; FTC wants more from Zimmer, Biomet on merger; Johnson & Johnson closes Ortho-Clinical Diagnostics sale
The U.S. Federal Trade Commission wants more information from Zimmer Holdings and Biomet on their proposed, $13 billion merger.
Zimmer Holdings and Biomet tap executives from both companies for a team to guide their integration after their pending $13 billion merger closes.
Zimmer (NYSE:ZMH) and Biomet appointed executives from both companies to manage their integration after their pending, $13 billion merger goes through.
Here's a look at some of the top Wall Street stories for medical device companies this week: Blockbuster: Medtronic in $43B deal to acquire Covidien; Medtronic buyout holds $80M in golden parachutes for Covidien execs; FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device; European Commission tables review of Zimmer's $13B acquisition of Biomet; Ackman takes Allergan to court to defend against poison pill
The European Commission tables its review of Zimmer Holdings' $13 billion acquisition bid for cross-town orthopedics rival Biomet, saying Zimmer's submission is incomplete.
The European Commission tabled its review of the pending, $13.35 billion merger between Zimmer (NYSE:ZMH) and Biomet, saying Zimmer's submission for the June 3 review was insufficient.
Here's a look at some of the top personnel stories for medical device companies this week: Layoffs: Zimmer aims to 'keep everybody' following $13.3B Biomet mega-merger; Op-Ed: How to survive the Zimmer/Biomet merger; Echo Therapeutics proxy war gets ugly amid alleged threats.
Here's a look at some of the top legal news stories for medical device companies this week: J&J's Conor MedSystems can't slip $100M Biotronik lawsuit; Supreme Court declines review of Baxter/Fresenius patent row; Medtronic, Edwards ink $750M heart valve settlement; Pa. Supreme Court to review $28M Zimmer verdict; Laid off Italian workers sue Haemonetics.